WAM
Wakefield Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-28,436
| Closed | -$522K | – | 164 |
|
2020
Q3 | $522K | Buy |
28,436
+220
| +0.8% | +$4.04K | 0.25% | 112 |
|
2020
Q2 | $504K | Sell |
28,216
-5,954
| -17% | -$106K | 0.24% | 118 |
|
2020
Q1 | $554K | Buy |
34,170
+4,460
| +15% | +$72.3K | 0.3% | 79 |
|
2019
Q4 | $535K | Buy |
+29,710
| New | +$535K | 0.22% | 121 |
|